about
Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenograftsIdentification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.Purification and characterization of bioactive his6-tagged recombinant human tissue inhibitor of metalloproteinases-1 (TIMP-1) protein expressed at high yields in mammalian cells.Impact of proteomics on bladder cancer research.Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.Towards discovery-driven translational research in breast cancer.The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.Proteomic strategies in bladder cancer: From tissue to fluid and back.Tumor interstitial fluid - a treasure trove of cancer biomarkers.Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment.Proteomic analysis of tissue samples in translational breast cancer research.Drug transporters in breast cancer: response to anthracyclines and taxanes.Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening.Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways.CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation.ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression.A combined proteome and ultrastructural localization analysis of 14-3-3 proteins in transformed human amnion (AMA) cells: definition of a framework to study isoform-specific differences.Chromatin-mediated transcriptional regulation by the yeast architectural factors NHP6A and NHP6B.Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohortNucleosome structure of the yeast CHA1 promoter: analysis of activation-dependent chromatin remodeling of an RNA-polymerase-II-transcribed gene in TBP and RNA pol II mutants defective in vivo in response to acidic activators.Molecular Oncology journal has moved to open accessChallenges and opportunities in oncoproteomics.Looking back, to go forwardProteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker.Proximity probing assays for simultaneous visualization of protein complexes in situ.Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.Identification of BLCAP as a novel STAT3 interaction partner in bladder cancer.Datin, a yeast poly(dA:dT)-binding protein, behaves as an activator of the wild-type ILV1 promoter and interacts synergistically with Reb1p.The net acid extruders NHE1, NBCn1 and MCT4 promote mammary tumor growth through distinct but overlapping mechanisms.Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1.Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer.Contribution of Na+,HCO3(-)-cotransport to cellular pH control in human breast cancer: a role for the breast cancer susceptibility locus NBCn1 (SLC4A7).Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.Proteogenomic characterization of patient-derived xenografts highlights the role of REST in neuroendocrine differentiation of castration-resistant prostate cancerPredictive value of combined analysis of pro-NPY and ERG in localized prostate cancerIdentification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell inter
P50
Q33597980-96F64C41-E46D-4903-8CF7-D34783B855DEQ33665522-00359034-1AE0-4200-A9B6-734023D0383CQ34977042-0F111EFE-11C4-4F5B-A0BE-2CFD6FC5D63EQ35202043-22C5E83B-0B78-454C-98AB-E62FFFD69CDCQ35785226-5BE9E1AF-D6FB-44D4-81A7-3BFF9E7F01A6Q35902206-4DB25EEB-B49C-4AFD-BBBD-415B01ACE8BFQ36000899-45980D8F-B186-49A0-B179-77028AB0FF7BQ36045385-C8980780-2F96-4639-B657-47A5B5A02EDEQ36456638-0B6C215C-1862-4A3B-BAAB-05BC1FCA06D4Q37413146-CB03A9E3-0FA7-4CB3-98CF-912ED22EF025Q37817248-2503D11E-1A71-4C0E-95E5-2AC2F3F6F579Q38082286-FF01D214-69CB-4D68-80AC-2180CDCB46D1Q38184981-46F37FCF-5CA9-46E7-AC50-26C4B9B9B782Q38212502-581FF55F-43F7-47AA-8BDF-428F238C3698Q38575008-D24E12ED-E56F-4E6D-B053-0639F4740349Q38672564-ECBE485A-3380-4EAC-B605-3F804CC3A701Q38901400-3D583A2C-FA18-44F3-A249-3A81C6FA9C9AQ38919039-772C182A-5FE9-4255-8DD4-1D8E6E311158Q39018985-2DAD0BF6-20AB-4ADB-BD08-1ECE8D3AFAA8Q39371752-9C95C585-5D1E-4A61-AEBE-339323DC8BF0Q39996618-448A1DDA-7AB1-4286-9B29-E8EDDABE6E6BQ40388477-0D44968B-1DFB-49BD-BB38-27F955A042E4Q41130064-A681A136-A99E-410F-8F97-4D8DC99080D1Q42002467-A0BDC13F-CB9F-4749-8E05-8A7D9775C9EAQ42337311-6383295C-64DF-4833-9D3F-40A9C9E3C933Q42337400-B1FED186-3CD7-45E2-ADBC-F1778944BEC4Q42337536-2C984D3B-E9EC-4183-B367-FCA1CB6AB07DQ45365018-1D71024A-7ED0-4D32-8016-38CB014CBF0BQ46025508-98E4266D-3DC9-47D0-9A66-B7C8B354FE6BQ46827099-D1231D0A-F925-41A4-A20D-B1EE32D54DA8Q47099158-516B7A83-E076-49C4-BB65-FC4EDED3D9DCQ48012467-52E01BBB-40F1-49BE-A0FD-D5768D650BA7Q48178908-791DBC06-3471-4913-89EB-2BE7158BC44EQ49358483-42EA8F31-196E-44EF-BBEB-FFCBFEE06677Q53552603-3DE38761-386D-4760-9B6E-C9AEBB668507Q54489613-94D4E5A2-6EC9-42F7-A8E8-FA7718EBDA82Q55059317-F12B381B-824D-469A-AB4F-BCE74B0D9D85Q57053752-8CD7C018-178F-416F-BDC8-3B28B77EF5A4Q70462173-1DCC31B1-0948-4E1F-ACAC-C5CA1D7D8860Q81369509-A4361675-3822-43AB-83D1-F8D139977919
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
José Moreira
@ast
José Moreira
@en
José Moreira
@es
José Moreira
@nl
type
label
José Moreira
@ast
José Moreira
@en
José Moreira
@es
José Moreira
@nl
prefLabel
José Moreira
@ast
José Moreira
@en
José Moreira
@es
José Moreira
@nl
P1153
8748349200
P21
P31
P496
0000-0002-9944-1214